Top-Searched Lab Tests
Explore Conditions
Explore Biomarkers
Explore Diagnostic Labs
New Lab Tests
| Test Name | Methodology | Specimen | TAT | Lab |
|---|---|---|---|---|
| NeoTYPE Melanoma Profile | NGS | Tissue | 14 d | NeoGenomics |
| FoundationOne®CDx | NGS | Tissue | 8 d | Foundation Medicine |
| PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD) | Chromosomal / Cytogenetics | Tumor Tissue | — | ARUP Laboratories |
| KIT (D816V) Mutation by ddPCR, Quantitative | PCR-based | Whole Blood, Bone Marrow | 2-9 d | ARUP Laboratories |
| AAV5 Detect CDxTM -AAV5 Total Antibody Assay for ROCTAVIAN (valoctocogene roxaparvovec-rvox) Eligibility in Hemophilia A | Immunoassay | Plasma | 8-10 d | ARUP Laboratories |
NeoTYPE Melanoma Profile
Methodology:NGS
Specimen:Tissue
TAT:14 d
Lab:NeoGenomics
FoundationOne®CDx
Methodology:NGS
Specimen:Tissue
TAT:8 d
Lab:Foundation Medicine
PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD)
Methodology:Chromosomal / Cytogenetics
Specimen:Tumor Tissue
TAT:—
Lab:ARUP Laboratories
KIT (D816V) Mutation by ddPCR, Quantitative
Methodology:PCR-based
Specimen:Whole Blood, Bone Marrow
TAT:2-9 d
Lab:ARUP Laboratories
AAV5 Detect CDxTM -AAV5 Total Antibody Assay for ROCTAVIAN (valoctocogene roxaparvovec-rvox) Eligibility in Hemophilia A
Methodology:Immunoassay
Specimen:Plasma
TAT:8-10 d
Lab:ARUP Laboratories
Featured Companion Diagnostics
| Test Name | Methodology | Specimen | TAT | Lab |
|---|---|---|---|---|
| xT CDx | NGS | Tissue, Whole Blood, Saliva | 10-14 d | Tempus AI |
| Vysis Chronic Lymphocytic Leukemia (CLL) Panel | Chromosomal / Cytogenetics | Whole Blood, Bone Marrow | 5 d | MPLN |
| PMS2 Microsatellite Instability, technical only | Immunoassay | Tissue, Tissue, Tissue | 2 d | MPLN |
| PMS2 Microsatellite Instability | Immunoassay | Tissue, Tissue, Tissue | 2 d | MPLN |
| PD-L1 (SP263), technical only | Immunoassay | Tissue, Tissue, Tissue | 2 d | MPLN |
xT CDx
Methodology:NGS
Specimen:Tissue, Whole Blood, Saliva
TAT:10-14 d
Lab:Tempus AI
Vysis Chronic Lymphocytic Leukemia (CLL) Panel
Methodology:Chromosomal / Cytogenetics
Specimen:Whole Blood, Bone Marrow
TAT:5 d
Lab:MPLN
PMS2 Microsatellite Instability, technical only
Methodology:Immunoassay
Specimen:Tissue, Tissue, Tissue
TAT:2 d
Lab:MPLN
PMS2 Microsatellite Instability
Methodology:Immunoassay
Specimen:Tissue, Tissue, Tissue
TAT:2 d
Lab:MPLN
PD-L1 (SP263), technical only
Methodology:Immunoassay
Specimen:Tissue, Tissue, Tissue
TAT:2 d
Lab:MPLN